Innovation Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.005; its P/E ratio is -1.96; Innovation Pharmaceuticals is scheduled to report earnings on May 10, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 18.00K
Gross Profit	-	-	$ 14.00K	-	-
EBIT	-	$ -679.00K	$ -305.00K	$ -1.41M	$ -1.60M
EBITDA	-	$ -586.00K	$ -211.00K	$ -1.32M	$ -1.51M
Net Income Common Stockholders	$ 2.07M	$ -698.00K	$ -319.00K	$ -1.43M	$ -1.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.52M	$ 1.94M	$ 2.42M	$ 2.97M	$ 3.81M
Total Assets	$ 7.52M	$ 7.99M	$ 8.69M	$ 9.34M	$ 10.38M
Total Debt	$ 268.00K	$ 346.00K	$ 393.00K	$ 450.00K	$ 502.00K
Net Debt	$ -1.25M	$ -1.59M	$ -2.03M	$ -2.52M	$ -3.31M
Total Liabilities	$ 5.48M	$ 5.28M	$ 5.61M	$ 5.92M	$ 5.65M
Stockholders Equity	$ 2.04M	$ 2.72M	$ 3.08M	$ 3.42M	$ 4.73M
Cash Flow	-
Free Cash Flow	-	$ -469.00K	$ -477.00K	$ -795.00K	$ -988.00K
Operating Cash Flow	$ -369.00K	$ -469.00K	$ -477.00K	$ -791.00K	$ -958.00K
Investing Cash Flow	$ -12.00K	$ -17.00K	$ -27.00K	$ -4.00K	$ -4.03M
Financing Cash Flow	$ -41.00K	$ 3.00K	$ -41.00K	$ -44.00K	$ 0.00

Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

Income Statement >

Innovation Pharmaceuticals Debt to Assets

Balance Sheet >

Innovation Pharmaceuticals Cash Flow

Cash Flow >

Innovation Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing